What's in Kyowa Kirin Korea Co., Ltd.'s pipeline?

Kyowa Kirin Korea Co., Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Kyowa Kirin Korea Co., Ltd.'s portfolio?

Top competitors by shared drug class: Amgen, Centro de Atencion e Investigacion Medica, Eisai Inc., GlaxoSmithKline, Hvidovre University Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kyowa-kirin-korea-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Kyowa Kirin Korea Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kyowa Kirin Korea Co., Ltd. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Hematology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amgen · 1 shared drug class
Centro de Atencion e Investigacion Medica · 1 shared drug class
Eisai Inc. · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hvidovre University Hospital · 1 shared drug class
Institute of Hematology & Blood Diseases Hospital, China · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Peking Union Medical College Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kyowa Kirin Korea Co., Ltd.:

Cite this brief

Drug Landscape (2026). Kyowa Kirin Korea Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kyowa-kirin-korea-co-ltd. Accessed 2026-05-16.